DUALITYBIO-B(09606): It is recommended that the RMB shares be listed on the Sci-Tech Innovation Board with the guidance and acceptance of the Shanghai Regulatory Authority.

date
06:25 10/06/2026
avatar
GMT Eight
Yinge Biotech-B (09606) has announced that the proposed listing of ordinary shares on the Shanghai Stock Exchange STAR Market for trading in Renminbi (recommended for listing). The company is currently receiving guidance from CITIC Securities Co., Ltd., and the guidance has been accepted by the Shanghai Regulatory Bureau of the China Securities Regulatory Commission.
DUALITYBIO-B (09606) has issued an announcement regarding its planned issuance of ordinary shares to be listed on the Shanghai Stock Exchange Science and Technology Innovation Board and traded in Renminbi (proposed listing). The company is currently receiving guidance from CITIC SEC Limited, and the relevant guidance has been approved by the Shanghai Regulatory Bureau of the China Securities Regulatory Commission.